| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $7.4M+64.5% | $4.5M+90.2% | $2.4M+106.5% | $1.1M |
| General, administrative and other | $9.2M+0.1% | $9.2M+41.6% | $6.5M+96.4% | $3.3M |
| Total operating expenses | $16.6M+21.2% | $13.7M+54.5% | $8.9M+99.0% | $4.5M |
| Loss from operations | -$16.6M-21.2% | -$13.7M-54.5% | -$8.9M-99.0% | -$4.5M |
| Change in fair value of warrant liability | $0-100.0% | $5.4M+174.4% | -$7.2M | — |
| Change in fair value of forward contract liability | $0+100.0% | -$417K | — | — |
| Change in fair value of SEPA put option liability | $352K+176.5% | -$460K | — | — |
| Change in fair value of convertible debt | -$1.8M-864.2% | $232K | — | — |
| Commitment fee expenses | $0+100.0% | -$2.2M | — | — |
| Placement agent and tail fee expenses | $0+100.0% | -$1.4M | — | — |
| Other income/(expense) | -$619K-2034.4% | $32K+115.0% | -$213K | — |
| Gain on termination of warrant and commitment fee liabilities | $0-100.0% | $1.2M | — | — |
| Interest income | $247K-1.6% | $251K | — | — |
| Interest expense | -$204K-920.0% | -$20K+86.4% | -$147K+77.5% | -$654K |
| Total other income/(expense) | -$2.0M-177.5% | $2.6M | — | — |
| Net loss | -$18.6M-67.1% | -$11.2M+32.3% | -$16.5M-221.9% | -$5.1M |
| Net loss per share, basic | -$420.00-23.5% | -$340.00+50.0% | -$680.00-277.8% | -$180.00 |
| Net loss per share, diluted | -$420.00-23.5% | -$340.00+50.0% | -$680.00-277.8% | -$180.00 |
| Weighted-average shares outstanding, basic | 44.66B+35.8% | 32.88B+16.5% | 28.23B+0.0% | 28.23B |
| Weighted-average shares outstanding, diluted | 44.66B+35.8% | 32.88B+16.5% | 28.23B+0.0% | 28.23B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.